Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 349.00
+17.00 (5.12%)
Jun 3, 2026, 3:30 PM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 11.63 billion as of June 2, 2026. Its market cap has increased by 3.56% in one year.
Market Cap
11.63B
Enterprise Value
9.55B
Revenue
323.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
349.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 11.63B, a decrease of -50.98%. That is a compound annual growth rate of -13.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 11.63B | 68.35% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 17.93B |
| RaQualia Pharma | 13.04B |
| ReproCELL | 11.69B |
| CanBas | 11.10B |
| Immuno-Biological Laboratories | 9.46B |
| Nano Holdings | 9.27B |
| CellSeed | 9.23B |
| Carna Biosciences | 8.65B |